Seeking Alpha

NVGN
  Novogen Limited - NASDAQ

10/31/2014, 4:02 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
NVGN vs. ETF Alternatives
Company Description
Novogen Ltd is engaged in pharmaceutical drug development. It develops single drug capable of killing both the dominant differentiated cells in a cancer as well as the undifferentiated cancer stem cells at a therapeutic dose.